Business Context and Reporting Period
Company: Revelation Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2025
Event: Cancellation of an adjourned Special Meeting of Stockholders due to technical difficulties preventing shareholders from voting all shares.
Key Financial Metrics
This filing is a regulatory disclosure regarding corporate governance and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Meeting Cancellation: The Special Meeting of Stockholders, previously adjourned to October 29, 2025, was canceled at 12:00 PM ET.
- Reason for Cancellation: Technical difficulties outside the Company's control resulted in stockholders being unable to vote all of their shares.
- New Schedule: A new Special Meeting of Stockholders is scheduled for December 3, 2025.
- Record Date: The new record date for the rescheduled meeting is set as October 29, 2025.
Guidance, Outlook, and Risks
Management Commentary: Management confirmed the cancellation was necessary due to voting system failures and has established a new timeline for shareholder action.
Risks and Contingencies: The primary risk identified is the operational disruption caused by technical failures in the voting process, necessitating a delay in shareholder decisions. No financial risks or unusual items were disclosed in this specific report.
Investor Verification Checklist
- Verify the new date and time for the Special Meeting of Stockholders (December 3, 2025).
- Confirm the new record date (October 29, 2025) to ensure eligibility to vote.
- Review the attached press release (Exhibit 99.1) for specific details on the technical difficulties and the agenda for the rescheduled meeting.
- Monitor future filings for the outcome of the rescheduled Special Meeting.